| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039745 |
| Receipt No. | R000045323 |
| Scientific Title | The effectiveness of physical exercise training in patients with non-dialysis chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials |
| Date of disclosure of the study information | 2020/03/12 |
| Last modified on | 2020/11/29 (Ver. 4) |
| Basic information | ||
| Public title | The effectiveness of physical exercise training in patients with non-dialysis chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials | |
| Acronym | The effectiveness of physical exercise training in patients with non-dialysis chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials | |
| Scientific Title | The effectiveness of physical exercise training in patients with non-dialysis chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials | |
| Scientific Title:Acronym | The effectiveness of physical exercise training in patients with non-dialysis chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials | |
| Region |
|
|
| Condition | |||
| Condition | adult participants (18 years or older) with stage 2-5 chronic kidney disease with non dialysis. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine effectiveness of physical exercise training on physical function, kidney function and all-cause mortality in patients with non-dialysis chronic kidney disease |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1) All cause mortality
2) Kidney function (eGFR, serum creatinine, proteinuria) 3) Physical capacity (peak/maximum oxygen uptake) |
| Key secondary outcomes | 1) Adverse events
2) Physical function (muscle strength, time up go test, 6-min walking test) 3) Health-related quality of life |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | We will include adult participants (18 years or older) with stage 2-5 chronic kidney disease with non dialysis. | |||
| Key exclusion criteria | We will exclude participants who have undergone a renal replacement therapy such as dialysis or a kidney transplant. | |||
| Target sample size | ||||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Matsumoto City Hospital | ||||||
| Division name | Rehabilitation | ||||||
| Zip code | 390-1401 | ||||||
| Address | 4417-180, Hata, Matsumoto, Nagano | ||||||
| TEL | 0263-92-3027 | ||||||
| keipons55@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Matsumoto City Hospital | ||||||
| Division name | Rehabilitation | ||||||
| Zip code | 390-1401 | ||||||
| Address | 4417-180, Hata, Matsumoto | ||||||
| TEL | 0263-92-3027 | ||||||
| Homepage URL | |||||||
| keipons55@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Matsumoto City Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Matsumoto City Hospital |
| Address | 4417-180, Hata, Matsumoto |
| Tel | 0263-92-3027 |
| keipons55@yahoo.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | https://www.nature.com/articles/s41598-020-75405-x |
| Number of participants that the trial has enrolled | 848 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Two review authors will screen search results (title and abstract) of all potentially relevant studies as a result of the search. We will assess the full-text study reports/publications and two review authors will independently screen the full-text and identify studies for inclusion. We will resolve any disagreement in discussion or we will consult other review authors.
We will use a data collection form for study characteristics and outcome data, which has been piloted on at least one study in the review. Two review authors (KN and TS) will extract characteristics from included studies, as follows: Methods: study design, total duration of study, location, study setting, withdrawals, and date of study. Participants: N, mean age, age range, gender, severity of condition, diagnostic criteria, cause of kidney disease, inclusion criteria, and exclusion criteria. Interventions: intervention, comparison. Outcomes: primary and secondary outcomes specified and collected, and time points reported. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000045323 |